CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.42B, above the global median of $1.15B
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.42BUSDvs all stocks (USD)
Revenue (TTM)
101.66MUSDvs all stocks (USD)
Profit Margin
-2.91%vs Medical Instruments & Supplies peers
Beta
1.94xvs all stocks
52-Week Change
40.41%vs all stocks
Market Capitalization
1.42BUSDvs all stocks (USD)
Enterprise Value
1.41BUSDvs all stocks (USD)
Forward P/E
91.70xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
14.54xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.97xvs Medical Instruments & Supplies peers
Enterprise to Revenue
13.89xvs Medical Instruments & Supplies peers
Gross Margin
63.62%vs Medical Instruments & Supplies peers
Profit Margin
-2.91%vs Medical Instruments & Supplies peers
Operating Margin
0.10%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.09%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-3.09%vs Medical Instruments & Supplies peers
Revenue (TTM)
101.66MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.11USDUpdated Jul 18, 2026Quarterly Revenue Growth
24.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
64.81MUSDvs all stocks (USD)
EBITDA (TTM)
4.32MUSDvs all stocks (USD)
Net Income (TTM)
-11.21MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
14.87%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
17.90MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
6.39MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
96.21MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
34.10MUSDFY2025 · Dec 31, 2025Gross Profit
62.12MUSDFY2025 · Dec 31, 2025Operating Income
-16.60MUSDvs all stocks (USD)
Pre-tax Income
-12.08MUSDFY2025 · Dec 31, 2025Income Tax Expense
49.00KUSDFY2025 · Dec 31, 2025Net Income
-4.59MUSDFY2025 · Dec 31, 2025EBIT
-16.60MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-11.91MUSDFY2025 · Dec 31, 2025Research & Development
23.09MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
55.37MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-4.59MUSDFY2025 · Dec 31, 2025Operating Cash Flow
37.73MUSDFY2025 · Dec 31, 2025Free Cash Flow
28.25MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
33.04MUSDFY2025 · Dec 31, 2025Interest Paid
762.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-4.59MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
4.69MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
65.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
22.99MUSDFY2025 · Dec 31, 2025Other Non-cash Items
17.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
264.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.09MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-999.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-9.48MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-10.22MUSDFY2025 · Dec 31, 2025Net Acquisitions
23.52MUSDFY2025 · Dec 31, 2025Purchase of Investments
-116.06MUSDFY2025 · Dec 31, 2025Sale of Investments
41.59MUSDFY2025 · Dec 31, 2025Other Investing Activity
-886.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-61.32MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-10.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-942.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-10.94MUSDFY2025 · Dec 31, 2025Shares Outstanding
48.83MSharesUpdated Jul 18, 2026Float Shares
42.68MSharesUpdated Jul 18, 2026Shares Short
3.01MSharesUpdated Jul 18, 2026Short Ratio
2.66daysvs all stocks
Short % of Shares Outstanding
9.66%vs all stocks
% Held by Insiders
2.37%vs all stocks
% Held by Institutions
104.50%vs all stocks
Total Cash (MRQ)
81.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.66USDUpdated Jul 18, 2026Total Debt (MRQ)
14.86MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0399xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
7.30xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.62USDUpdated Jul 18, 2026Total Assets
405.88MUSDvs all stocks (USD)
Total Current Assets
136.56MUSDFY2025 · Dec 31, 2025Total Liabilities
34.00MUSDFY2025 · Dec 31, 2025Total Non-current Assets
269.32MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
11.02MUSDFY2025 · Dec 31, 2025Total Current Liabilities
22.98MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
33.04MUSDFY2025 · Dec 31, 2025Other Short-term Investments
55.89MUSDFY2025 · Dec 31, 2025Accounts Receivable
7.95MUSDFY2025 · Dec 31, 2025Inventory
30.16MUSDFY2025 · Dec 31, 2025Accounts Payable
1.49MUSDFY2025 · Dec 31, 2025Short-term Debt
7.24MUSDFY2025 · Dec 31, 2025Deferred Revenue
195.00KUSDFY2025 · Dec 31, 2025Long-term Debt
10.66MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
171.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
48.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-339.70MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
371.89MUSDvs all stocks (USD)
52-Week Low
17.86USDUpdated Jul 18, 202652-Week High
30.88USDUpdated Jul 18, 202652-Week Change
40.41%vs all stocks
Beta
1.94xvs all stocks
50-Day MA
25.68USDUpdated Jul 18, 2026200-Day MA
24.17USDUpdated Jul 18, 2026Avg 10-Day Volume
591.88KSharesUpdated Jul 18, 2026Avg 30-Day Volume
931.26KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.2500USDUpdated Jul 18, 2026Other Income / Expense
1.81MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: -0.03
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.42B, above the global median of $1.15BNotable
Market cap (USD): 1,424,193,647Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Onmicro Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Guangzhou Sanfu New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Privi Speciality Chemicals Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Taihan Fiberoptics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Haili Wind Power Equipment Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Weifu High Technology Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Zhongli Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wankai New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Kestra Medical Technologies, Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Lumax Auto Technologies Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
OmniAb, Inc.
2 interpretationsGoodwill-Heavy EquityMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Celltrion Inc.
2 interpretationsCash-Flow Ratios ElevatedGoodwill-Heavy Equity
Waystar Holding Corp.
2 interpretationsCash-Flow Ratios ElevatedGoodwill-Heavy Equity